All News

Clinical Trials

Innovation in an Integrated and Robust Clinical Trials and Biomaterials Solution
18 January 2022
Innovation in an Integrated and Robust Clinical Trials and Biomaterials Solution
Interview - Q&A
Humacyte’s First Preclinical Results of HAV™ in Coronary Artery Bypass Grafting to be Presented at Advanced Therapies Week – A Further Development in their HAV Portfolio
5 January 2022
Humacyte’s First Preclinical Results of HAV™ in Coronary Artery Bypass Grafting to be Presented at Advanced Therapies Week – A Further Development in their HAV Portfolio
News
Ask and You Shall Receive: A GMP Pandemic Response, 3 Priorities from the Covid-19 Vaccine Development Process
22 December 2021
Ask and You Shall Receive: A GMP Pandemic Response, 3 Priorities from the Covid-19 Vaccine Development Process
Blog
Early Clinical Trial Results Suggest a Step Towards the First In Vivo Genome Editing Opportunity in Children
20 October 2021
Early Clinical Trial Results Suggest a Step Towards the First In Vivo Genome Editing Opportunity in Children
News
POPULAR NEWS ITEMS
Image
24 January 2022

M&A Shines Bright in Life Science

Image
20 January 2022

$100 Million Series B Funding Raised by Ori Biotech, Progressing the Launch of their Innovative Cell and Gene Therapy Manufacturing Platform

Image
1 January 0208

Protected: The Importance of Innovation and Problem Solving in Scaling Up GMP Manufacturing

Kite’s Tecartus® Approved by FDA as First CAR-T for Adults with Relapsed or Refractory B-cell Acute Lymphoblastic Leukaemia
6 October 2021
Kite’s Tecartus® Approved by FDA as First CAR-T for Adults with Relapsed or Refractory B-cell Acute Lymphoblastic Leukaemia
News
FDA Lifts Clinical Hold on Rocket’s Danon Disease Gene Therapy Trial
19 August 2021
FDA Lifts Clinical Hold on Rocket’s Danon Disease Gene Therapy Trial
News
Clinical Trial Collaboration Announced to Explore Combination Therapy in Patients with Advanced Solid Tumours
11 August 2021
Clinical Trial Collaboration Announced to Explore Combination Therapy in Patients with Advanced Solid Tumours
The Phase I/IIa clinical trial
Cell Therapy Trial for Post-Covid-19 Fibrotic Lung Disease a ‘World First’
22 July 2021
Cell Therapy Trial for Post-Covid-19 Fibrotic Lung Disease a ‘World First’
Load more News
RECOMENDED TOPICS
Clinical Trials
Collaborations, Mergers & Acquisitions
Finance & Investment
Patient Access & Engagement
Regulatory & Standards
Reimbursement
Strategy
POPULAR NEWS ITEMS
Image

M&A Shines Bright in Life Science

Image

$100 Million Series B Funding Raised by Ori Biotech, Progressing the Launch of their Innovative Cell and Gene Therapy Manufacturing Platform

Image

Protected: The Importance of Innovation and Problem Solving in Scaling Up GMP Manufacturing